← Evidence map

ReviewDrug safety2002

A benefit-risk assessment of extended-release oxybutynin.

Martin C MichelPubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

this paperpooled itcites it

A benefit-risk assessment of extended-release oxybutynin. | OpenQuestion